Aequus (TSX-V: AQS) Licenses Rights to Cannabinoid Transdermal Patch to Treat Neurological Disorders
Vancouver, BC. March 2, 2017– Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”) announced today that through a previously announced Research Service Contract with Transdermal Research…
Read More